SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-23-001035
Filing Date
2023-06-12
Accepted
2023-06-12 16:13:21
Documents
14
Period of Report
2023-06-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm   iXBRL 8-K 22599
  Complete submission text file 0001640334-23-001035.txt   142161

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20230606.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20230606_lab.xml EX-101.LAB 14064
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20230606_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20230606_pre.xml EX-101.PRE 8883
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20230606_def.xml EX-101.DEF 2099
8 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_8k_htm.xml XML 3483
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 231008200
SIC: 2834 Pharmaceutical Preparations